Loading the section
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
BioRestorative Therapies, Inc. trades on Nasdaq under the ticker BRTX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks BRTX has traded between 0.1425 $ and 3.23 $. As of 09 October 2026 the price stood 56.60 % of the way from the 52-week low to the high.
Over one year BRTX shares rose 16.67 %; over six months they rose 687.50 %. Volatility over 90 days is 504.84 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2.4, below the sector median of 3.9. Price to book is 0.3, below the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 2.18 | 2.18 | 1.75 | 1.89 | 95,600 |
| 07 October 2026 | 2.30 | 2.30 | 2.05 | 2.24 | 37,800 |
| 06 October 2026 | 2.20 | 2.29 | 2.14 | 2.27 | 79,700 |
| 05 October 2026 | 2.16 | 2.31 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:40 MARCUS DRIVE, MELVILLE, NY, 11747, US
BioRestorative Therapies, Inc. reported revenue of 357,870 $ and a net loss of 11M $ over the last four quarters. Net margin is −3,089.55 %. Revenue changed by −8.47 % year over year. Earnings per share are −21.20 $. Market capitalisation is 851,814 $.
BRTX has a return on equity of −365.43 %, below the sector median of −41.68 %. Return on assets is −238.27 %, below the sector median of −32.11 %. Operating margin is −3,975.00 %, below the sector median of −26.84 %.
| 19M |
| NIVFNewGenIvf Group Limited | 0.0721 | −31.98 % | 8M |
| VMDViemed Healthcare, Inc. | 9.52 | +1.17 % | 2M |
| MGRXMangoceuticals, Inc. | 0.4220 | −2.31 % | 249,358 |
| CCELCryo-Cell International, Inc. | 4.36 | +4.56 % | 56,385 |
| 2.01 |
| 2.24 |
| 85,200 |
| 02 October 2026 | 2.26 | 2.43 | 2.14 | 2.14 | 25,500 |
| 01 October 2026 | 2.28 | 2.47 | 2.25 | 2.27 | 21,500 |
| 30 September 2026 | 2.26 | 2.39 | 2.26 | 2.33 | 24,900 |
| 29 September 2026 | 2.32 | 2.34 | 2.26 | 2.33 | 15,100 |
| 28 September 2026 | 2.42 | 2.49 | 2.29 | 2.31 | 49,400 |
| 25 September 2026 | 2.55 | 2.68 | 2.45 | 2.55 | 28,500 |
| 24 September 2026 | 2.59 | 2.69 | 2.51 | 2.51 | 24,300 |
| 23 September 2026 | 2.61 | 2.90 | 2.53 | 2.60 | 85,200 |
| 22 September 2026 | 2.72 | 2.93 | 2.50 | 2.55 | 67,000 |
| 21 September 2026 | 2.70 | 2.75 | 2.68 | 2.71 | 26,800 |
| 18 September 2026 | 2.71 | 2.79 | 2.67 | 2.69 | 17,400 |
| 17 September 2026 | 2.66 | 2.74 | 2.58 | 2.66 | 12,400 |
| 16 September 2026 | 2.62 | 2.67 | 2.55 | 2.55 | 15,500 |
| 15 September 2026 | 2.73 | 2.77 | 2.62 | 2.64 | 9,600 |
| 14 September 2026 | 2.68 | 2.74 | 2.66 | 2.70 | 7,100 |
| 11 September 2026 | 2.75 | 2.78 | 2.63 | 2.67 | 10,300 |